Glucose Tolerance Test Interpretation
A 52-year-old patient with a BMI of 31 reports fatigue and increased thirst. Fasting glucose is 118 mg/dL and fasting insulin is elevated at 22 µU/mL. A 75 g oral glucose tolerance test gives glucose values of 118 mg/dL at 0 min, 210 mg/dL at 60 min, 190 mg/dL at 120 min, and 150 mg/dL at 180 min. Insulin rises to 180 µU/mL at 60 min and remains 120 µU/mL at 120 min. Hemoglobin A1c is 6.1%. One student says the patient has type 1 diabetes because glucose is still high at 2 hours and recommends starting insulin injections. Another says the patient has type 2 diabetes because the insulin level is high, showing insulin resistance. The patient asks whether these results prove the diagnosis and whether medication is needed now.
1. Using standard diagnostic criteria, classify the patient's fasting glucose, 2-hour glucose, and HbA1c. Does the patient meet criteria for diabetes?
Read the worked answer
The fasting glucose of 118 mg/dL falls in the impaired fasting glucose range, typically 100–125 mg/dL. A value of 126 mg/dL or higher on a confirmed test would meet the diabetes threshold. The 2-hour glucose of 190 mg/dL falls in the impaired glucose tolerance range, typically 140–199 mg/dL; 200 mg/dL or higher would meet the diabetes threshold. The 60-minute value of 210 mg/dL is not used as a diagnostic threshold in the standard 2-hour test. The HbA1c of 6.1% falls in the prediabetes range, typically 5.7–6.4%; 6.5% or higher would meet the diabetes threshold.
The correct classification is prediabetes, with both impaired fasting glucose and impaired glucose tolerance, not diabetes. The student who says type 1 diabetes is incorrect because the diagnostic thresholds are not met and because the insulin response is high, not low. The other student is also overstating the evidence: high insulin suggests resistance, but the glucose values still place the patient in the prediabetes category, not the diabetes category. Confirmatory testing would be appropriate before any formal diagnosis.
2. Explain what the insulin response suggests about the underlying physiology and why type 1 diabetes is unlikely.
Read the worked answer
Fasting insulin of 22 µU/mL is elevated, and the stimulated insulin rises to 180 µU/mL. That pattern indicates that the beta cells are still capable of a large secretory response. In type 1 diabetes, autoimmune destruction of beta cells typically produces low or undetectable insulin and C-peptide, often with ketosis and rapid symptom onset. This patient's high insulin is not consistent with that picture.
The combination of impaired fasting glucose and impaired glucose tolerance with high insulin suggests insulin resistance: the tissues respond poorly, so the pancreas compensates by secreting more insulin. Over time, compensatory hyperinsulinemia may fail, but at this stage the beta-cell response is robust. A high BMI and age are consistent with this physiology. However, insulin levels alone do not prove type 2 diabetes. Atypical forms, including latent autoimmune diabetes in adults, can present in this age group, so if the clinical picture were unusual, C-peptide and diabetes autoantibodies would help clarify. In this case, the glucose values do not yet meet diabetes criteria at all.
3. The patient asks whether medication is needed now. What is a defensible response based on the evidence, and what further information would you want?
Read the worked answer
A defensible response is that the results indicate prediabetes and insulin resistance, not diabetes, so insulin injections are not indicated. The first-line approach is intensive lifestyle change: dietary modification, weight loss, and regular physical activity, which can reduce progression to diabetes. Medication is not automatically required for prediabetes, but guidelines allow consideration of metformin in selected high-risk patients, such as those with BMI at least 35, age under 60, prior gestational diabetes, or an HbA1c in the higher prediabetes range. This patient's BMI is 31 and age is 52, so the decision depends on additional risk factors.
Before deciding, I would want repeat confirmatory glucose testing, a careful medication history, blood pressure, lipid panel, family history of diabetes, history of gestational diabetes, and symptoms of sleep apnea or other comorbidities. I would also want to know whether the fasting sample was truly fasting and whether the patient was acutely ill. The patient should be told that the OGTT is a snapshot and that the high insulin does not by itself establish the type of diabetes or the need for medication.